Merck's enlicitide pill lowered LDL cholesterol by up to 60%, matching injectables like Repatha and offering an easier option ...
The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease ...
At 12 weeks, a combination pill containing candesartan cilexetil, amlodipine, and chlorthalidone improved BP in patients with hypertension.
The founders of Metsera have a battle to buy their company. It would be their second time striking deal gold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback